Tesfahuneygn Gebrehiwet, Medhin Girmay, Legesse Mengistu
Lmlem Karl Hospital, P.O. Box, 07, Maichew, Ethiopia.
Aklilu Lemma Institutes of Pathobiology, Addis Ababa University, Addis Ababa, Ethiopia.
BMC Res Notes. 2015 Sep 29;8:503. doi: 10.1186/s13104-015-1452-x.
Non-adherence to tuberculosis (TB) treatment can result in an emergence of new strains, prolonged infectiousness, drug resistance and poor treatment outcomes. Thus, assessment of the level of adherence to anti-TB treatment, treatment outcomes and identifying factors associated with non-adherence and poor treatment outcomes are vital for improving TB treatment adherence and treatment outcomes in the study area. The main objectives of the current study were to assess the level of adherence to anti-TB treatment among patients taking anti-TB drug treatment and to identify factors associated with non-adherence. Whereas, the secondary objectives were to assess treatment outcomes and factors associated with poor treatment outcomes among TB patients previously treated at the health institutions of Alamata District, northeast Ethiopia.
In a health facility-based cross-sectional study, TB patients who were taking anti-TB drug treatment were interviewed using a structured questionnaire to evaluate level of adherence to anti-TB treatment. TB treatment outcomes were evaluated using data generated from a record review of previous TB patients who were treated at health facilities of Alamata District from January 2007 to June 2012. Adherence data and treatment outcomes data were computerized separately using Epi-Data version 3.1 and analyzed using STATA version 10.0.
Between November 2012 and January 2013, 116 (58.0%) male TB patients and 84 (42.0%) female TB patients were interviewed, of whom 77.5% were new cases, 23.5% were smear-positive pulmonary TB (SPPTB) cases, 26.5% were smear-negative PTB (SNPTB) cases and 50.0% were extra pulmonary (EPTB) cases. The overall adherence rate to anti-TB treatment was 88.5%. The main reasons for the non-adherent patients were forgetting to take medication, being away from home, drug side effects, being unable to go to the health facilities on the date of appointment and being hospitalized. In the TB treatment outcomes component of the current study, records of 4,275 TB patients were reviewed and the overall treatment success rate was 90.1%. Two-hundred fifteen (5.0%) patients had unsuccessful treatment outcomes, of whom 76 (35.3%) defaulted, 126 (58.6%) died and 13 (6.1%) had treatment failure. Significant predictors of unsuccessful treatment outcomes were being positive for human immunodeficiency virus (HIV) infection [adjusted odds ratio (aOR) = 2.1, 95% CI 1.5-3.0], being SPPTB case (aOR = 3.4, 95% CI 2.4-4.8), being SNPTB case (aOR = 2.0, 95% CI 1.5-2.8)], and being re-treatment cases (aOR = 2.6, 95% CI 1.5-3.7).
In the present study area, there was a high level of adherence to anti-TB treatment and also a high TB treatment success rate. However, still further effort like health education to patient or family is needed to reduce those factors which affect adherence and treatment success rates in order to ensure higher rates of adherence and treatment success than the currently observed in the present study area.
不坚持结核病(TB)治疗会导致新菌株出现、传染期延长、耐药性产生以及治疗效果不佳。因此,评估抗结核治疗的依从性水平、治疗效果以及确定与不依从和治疗效果不佳相关的因素,对于提高研究地区的结核病治疗依从性和治疗效果至关重要。本研究的主要目的是评估接受抗结核药物治疗的患者中抗结核治疗的依从性水平,并确定与不依从相关的因素。而次要目的是评估在埃塞俄比亚东北部阿拉马塔区卫生机构接受过治疗的结核病患者的治疗效果以及与治疗效果不佳相关的因素。
在一项基于医疗机构的横断面研究中,使用结构化问卷对正在接受抗结核药物治疗的结核病患者进行访谈,以评估抗结核治疗的依从性水平。利用2007年1月至2012年6月在阿拉马塔区卫生机构接受治疗的既往结核病患者的记录回顾所产生的数据,评估结核病治疗效果。使用Epi-Data 3.1版软件分别将依从性数据和治疗效果数据录入计算机,并使用STATA 10.0版软件进行分析。
在2012年11月至2013年1月期间,对116名(58.0%)男性结核病患者和84名(42.0%)女性结核病患者进行了访谈,其中77.5%为新病例,23.5%为涂片阳性肺结核(SPPTB)病例,26.5%为涂片阴性肺结核(SNPTB)病例,50.0%为肺外结核(EPTB)病例。抗结核治疗的总体依从率为88.5%。不依从患者的主要原因是忘记服药、离家外出、药物副作用、无法在预约日期前往医疗机构以及住院。在本研究的结核病治疗效果部分,对4275名结核病患者的记录进行了回顾,总体治疗成功率为90.1%。215名(5.0%)患者治疗效果不佳,其中76名(35.3%)中断治疗,126名(58.6%)死亡,13名(6.1%)治疗失败。治疗效果不佳的显著预测因素包括感染人类免疫缺陷病毒(HIV)呈阳性[调整优势比(aOR)=2.1,95%置信区间1.5 - 3.0]、为SPPTB病例(aOR = 3.4,95%置信区间2.4 - 4.8)、为SNPTB病例(aOR = 2.0,95%置信区间1.5 - 2.8)以及为复治病例(aOR = 2.6,95%置信区间1.5 - 3.7)。
在本研究地区,抗结核治疗的依从性水平较高,结核病治疗成功率也较高。然而,仍需要进一步努力,如对患者或家属进行健康教育,以减少那些影响依从性和治疗成功率的因素,从而确保获得比本研究地区目前观察到的更高的依从率和治疗成功率。